Francesca Morandi

1.5k total citations
24 papers, 1.0k citations indexed

About

Francesca Morandi is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Francesca Morandi has authored 24 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hematology, 12 papers in Oncology and 9 papers in Molecular Biology. Recurrent topics in Francesca Morandi's work include Multiple Myeloma Research and Treatments (14 papers), Bone health and treatments (8 papers) and Peptidase Inhibition and Analysis (4 papers). Francesca Morandi is often cited by papers focused on Multiple Myeloma Research and Treatments (14 papers), Bone health and treatments (8 papers) and Peptidase Inhibition and Analysis (4 papers). Francesca Morandi collaborates with scholars based in Italy, Brazil and United States. Francesca Morandi's co-authors include Nicola Giuliani, Vittorio Rizzoli, Sabrina Bonomini, Simona Colla, Mirca Lazzaretti, Sara Tagliaferri, Roberto Sala, Monica Crugnola, Mirija Svaldi and Silvia Colucci and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Francesca Morandi

24 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Francesca Morandi Italy 10 704 591 428 102 88 24 1.0k
Amanda Farrugia Australia 9 659 0.9× 306 0.5× 502 1.2× 68 0.7× 84 1.0× 11 1.0k
Gabriella Sammarelli Italy 16 438 0.6× 465 0.8× 404 0.9× 174 1.7× 89 1.0× 39 938
Ya‐Wei Qiang United States 16 685 1.0× 620 1.0× 1.1k 2.5× 62 0.6× 103 1.2× 35 1.6k
Marina Bolzoni Italy 19 610 0.9× 635 1.1× 562 1.3× 34 0.3× 164 1.9× 51 1.2k
Rosemary Mazanet United States 12 433 0.6× 293 0.5× 141 0.3× 187 1.8× 50 0.6× 29 741
Shingo Wakatsuki Japan 11 289 0.4× 203 0.3× 213 0.5× 70 0.7× 105 1.2× 29 657
Bei-Qing Pan China 12 566 0.8× 142 0.2× 482 1.1× 54 0.5× 68 0.8× 14 924
D. Soligo Italy 13 211 0.3× 449 0.8× 471 1.1× 84 0.8× 175 2.0× 20 1.1k
Cristina Panaroni United States 14 231 0.3× 248 0.4× 377 0.9× 106 1.0× 178 2.0× 31 908
Les Coulton United Kingdom 15 263 0.4× 187 0.3× 292 0.7× 51 0.5× 40 0.5× 22 761

Countries citing papers authored by Francesca Morandi

Since Specialization
Citations

This map shows the geographic impact of Francesca Morandi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesca Morandi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesca Morandi more than expected).

Fields of papers citing papers by Francesca Morandi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesca Morandi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesca Morandi. The network helps show where Francesca Morandi may publish in the future.

Co-authorship network of co-authors of Francesca Morandi

This figure shows the co-authorship network connecting the top 25 collaborators of Francesca Morandi. A scholar is included among the top collaborators of Francesca Morandi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesca Morandi. Francesca Morandi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pecora, Domenico, et al.. (2008). Performance of a Ventricular Automatic‐Capture Algorithm in a Wide Clinical Setting. Pacing and Clinical Electrophysiology. 31(12). 1546–1553. 1 indexed citations
2.
Giuliani, Nicola, Francesca Morandi, Sara Tagliaferri, et al.. (2007). Production of Wnt Inhibitors by Myeloma Cells: Potential Effects on Canonical Wnt Pathway in the Bone Microenvironment. Cancer Research. 67(16). 7665–7674. 81 indexed citations
3.
4.
5.
Giuliani, Nicola, Francesca Morandi, Sara Tagliaferri, et al.. (2007). The proteasome inhibitor bortezomib affects osteoblast differentiation in vitro and in vivo in multiple myeloma patients. Blood. 110(1). 334–338. 191 indexed citations
6.
Giuliani, Nicola, Francesca Morandi, Sara Tagliaferri, et al.. (2006). The Proteasome Inhibitor Bortezomib Affects Osteoblastogenesis and Bone Formation In Vitro and In Vivo in Multiple Myeloma Patients.. Blood. 108(11). 508–508. 3 indexed citations
7.
Giuliani, Nicola, Francesca Morandi, Sara Tagliaferri, & Vittorio Rizzoli. (2006). Targeting Pathways Mediating Bone Disease. Current Pharmaceutical Biotechnology. 7(6). 423–429. 5 indexed citations
8.
Colla, Simona, Francesca Morandi, Mirca Lazzaretti, et al.. (2005). Human myeloma cells express the bone regulating gene Runx2/Cbfa1 and produce osteopontin that is involved in angiogenesis in multiple myeloma patients. Leukemia. 19(12). 2166–2176. 59 indexed citations
9.
Ehrlich, Lori A., Ho Yeon Chung, Irene M. Ghobrial, et al.. (2005). IL-3 is a potential inhibitor of osteoblast differentiation in multiple myeloma. Blood. 106(4). 1407–1414. 147 indexed citations
10.
Giuliani, Nicola, Simona Colla, Francesca Morandi, et al.. (2005). Myeloma cells block RUNX2/CBFA1 activity in human bone marrow osteoblast progenitors and inhibit osteoblast formation and differentiation. Blood. 106(7). 2472–2483. 248 indexed citations
11.
Giuliani, Nicola, Paolo Lunghi, Francesca Morandi, et al.. (2004). Downmodulation of ERK protein kinase activity inhibits VEGF secretion by human myeloma cells and myeloma-induced angiogenesis. Leukemia. 18(3). 628–635. 68 indexed citations
12.
Colla, Simona, Gabriella Sammarelli, Monica Crugnola, et al.. (2004). Co‐existence of Philadelphia chromosome positive acute megakaryoblastic and B‐lymphoblastic mixed blast crisis of chronic myeloid leukemia with chronic lymphocytic leukemia. European Journal Of Haematology. 72(5). 361–365. 1 indexed citations
13.
Giuliani, Nicola, Simona Colla, Francesca Morandi, & Vittorio Rizzoli. (2004). Angiopoietin-1 and Myeloma-Induced Angiogenesis. Leukemia & lymphoma. 46(1). 29–33. 6 indexed citations
14.
Giuliani, Nicola, Simona Colla, Francesca Morandi, & Vittorio Rizzoli. (2004). The RANK/RANK ligand system is involved in interleukin-6 and interleukin-11 up-regulation by human myeloma cells in the bone marrow microenvironment.. PubMed. 89(9). 1118–23. 29 indexed citations
15.
Giuliani, Nicola, Simona Colla, Francesca Morandi, Sabrina Bonomini, & Vittorio Rizzoli. (2004). Myeloma Cells Block Runx2/Cbfa1 Activity in Human Bone Marrow Osteoblast Progenitors and Inhibit Osteoblast Formation and Differentiation.. Blood. 104(11). 632–632. 6 indexed citations
16.
Cappato, Riccardo, et al.. (2002). Role of Implantable Cardioverter Defibrillators in Dilated Cardiomyopathy. Journal of Cardiovascular Electrophysiology. 13(S1). S106–9. 4 indexed citations
17.
Mascioli, Giosuè, et al.. (1993). [Hypersensitivity and carotid sinus syndrome in patients with chronic atrial fibrillation].. PubMed. 23(10). 985–93. 2 indexed citations
18.
Pastorino, Ugo, Marco Gasparini, Luca Tavecchio, et al.. (1991). The contribution of salvage surgery to the management of childhood osteosarcoma.. Journal of Clinical Oncology. 9(8). 1357–1362. 66 indexed citations
19.
Gasparini, Marco, et al.. (1988). Combined radiotherapy and chemotherapy in stage T3 and T4 nasopharyngeal carcinoma in children.. Journal of Clinical Oncology. 6(3). 491–494. 47 indexed citations
20.
Orazi, Attilio, Gabriella Sozzi, D Delia, et al.. (1988). Acute Monoblastic Leukemia as a Second Malignancy Following Chemotherapy for Osteogenic Sarcoma: A Case Report. Pediatric Hematology and Oncology. 5(1). 39–46. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Amanda Farrugia Breakdown of academic impact, for papers by Gabriella Sammarelli Breakdown of academic impact, for papers by Ya‐Wei Qiang Breakdown of academic impact, for papers by Marina Bolzoni Breakdown of academic impact, for papers by Rosemary Mazanet Breakdown of academic impact, for papers by Shingo Wakatsuki Breakdown of academic impact, for papers by Bei-Qing Pan Breakdown of academic impact, for papers by D. Soligo Breakdown of academic impact, for papers by Cristina Panaroni Breakdown of academic impact, for papers by Les Coulton
Rankless by CCL
2026